BlackRock Reports Full Year 2024 Diluted EPS of $42.01, or $43.61 as Adjusted; Fourth Quarter 2024 Diluted EPS of $10.63, or $11.93 as Adjusted
Go back to BlackRock Reports Full Year 2024 Diluted EPS of $42.01, or $43.61 as Adjusted; Fourth Quarter 2024 Diluted EPS of $10.63, or $11.93 as Adjusted| BlackRock (NYSE: BLK) | Delayed: 1080.12 -15.25 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1095.37 | 52 Week High | $380.30 | |||
| Open | $1092.77 | 52 Week Low | $280.55 | |||
| Day High | $1092.89 | P/E | 64.03 | |||
| Day Low | $1078.37 | EPS | $16.87 | |||
| Volume | 140,768 | |||||
| BLACKROCK HEALTH SCIENCES TRUST (NYSE: BME) | Delayed: 44.50 -0.55 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.05 | 52 Week High | $43.64 | |||
| Open | $44.96 | 52 Week Low | $29.67 | |||
| Day High | $44.96 | P/E | N/A | |||
| Day Low | $44.50 | EPS | $0.00 | |||
| Volume | 16,285 | |||||

